Factor IX polypeptides and methods of use thereof
US10568943B2 · kind B2 · utility
4Cited by
46References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 8, 2019 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Feb 8, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/33
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of administering Factor IX; methods of administering chimeric and hybrid polypeptides comprising Factor IX; polynucleotides encoding such chimeric and hybrid polypeptides; cells comprising such polynucleotides; and methods of producing such chimeric and hybrid polypeptides using such cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.